The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Radovich Peter since 2016.
This trader's CIK number is 1650131.
At the time of last reporting, Radovich Peter was the PRESIDENT AND COO of Mirum Pharmaceuticals, Inc.. (stock ticker symbol MIRM).
Also see all insider trading activities at Mirum Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | GBT | 0 | $0 | 45,812 | $2,596,527 | 54,400 | $72,450 |
| 2017 | GBT | 0 | $0 | 14,910 | $509,800 | 3,000 | $0 |
| 2015 | GBT | 12,500 | $250,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | MIRM | 0 | $0 | 27,904 | $1,264,154 | 20,190 | $0 |
| 2024 | MIRM | 0 | $0 | 8,880 | $225,810 | 0 | $0 |
| 2023 | MIRM | 0 | $0 | 1,425 | $36,546 | 0 | $0 |
| 2021 | MIRM | 0 | $0 | 1,364 | $26,265 | 0 | $0 |
1. Global Blood Therapeutics, Inc. (GBT)
2. Mirum Pharmaceuticals, Inc. (MIRM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-02-14 | GBT | Option Ex | 1,600 | .00 | 0 |
| 2018-01-31 | GBT | Option Ex | 1,600 | .00 | 0 |
| 2018-02-01 | GBT | Sale | 812 | 57.30 | 46,527 |
| 2018-02-01 | GBT | Option Ex | 3,000 | .00 | 0 |
| 2018-01-24 | GBT | Option Ex | 1,600 | .00 | 0 |
| 2018-01-23 | GBT | Option Ex | 30,000 | 1.61 | 48,300 |
| 2018-01-23 | GBT | Sale | 30,000 | 60.00 | 1,800,000 |
| 2018-01-16 | GBT | Option Ex | 1,600 | .00 | 0 |
| 2018-01-10 | GBT | Option Ex | 15,000 | 1.61 | 24,150 |
| 2018-01-10 | GBT | Sale | 15,000 | 50.00 | 750,000 |
| 2017-10-30 | GBT | Sale | 12,500 | 35.00 | 437,500 |
| 2017-08-31 | GBT | Sale | 2,410 | 30.00 | 72,300 |
| 2017-08-01 | GBT | Option Ex | 3,000 | .00 | 0 |
| 2015-08-17 | GBT | Buy | 12,500 | 20.00 | 250,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-15 | MIRM | Option Ex | 14,440 | .00 | 0 |
| 2025-03-17 | MIRM | Sale | 7,879 | 44.21 | 348,362 |
| 2025-03-04 | MIRM | Sale | 14,850 | 45.66 | 677,991 |
| 2025-01-23 | MIRM | Option Ex | 5,750 | .00 | 0 |
| 2025-01-24 | MIRM | Sale | 3,177 | 47.92 | 152,257 |
| 2025-01-07 | MIRM | Sale | 1,998 | 42.81 | 85,544 |
| 2024-03-25 | MIRM | Sale | 4,303 | 25.80 | 111,017 |
| 2023-01-09 | MIRM | Sale | 1,379 | 20.62 | 28,437 |
| 2024-02-02 | MIRM | Sale | 1,790 | 26.19 | 46,883 |
| 2024-01-08 | MIRM | Sale | 1,408 | 28.04 | 39,473 |
| 2023-07-03 | MIRM | Sale | 1,425 | 25.65 | 36,546 |
| 2021-10-01 | MIRM | Sale | 1,364 | 19.26 | 26,265 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Radovich Peter (PRESIDENT AND COO of Mirum Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.